Biosynthesis of Structurally Novel Carotenoids in Escherichia coli  by Lee, Pyung Cheon et al.
Chemistry & Biology, Vol. 10, 453–462, May, 2003, 2003 Elsevier Science Ltd. All rights reserved. DOI 10.1016/S1074-5521(03)00103-0
Biosynthesis of Structurally Novel
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synthase (CrtE) and phytoene synthase (CrtB) to form
the colorless carotenoid phytoene. The introduction of
additional double bonds into phytoene by phytoene de-
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and Biophysics saturase (CrtI) produces the colored carotenoids neu-
1479 Gortner Avenue rosporene (three desaturations) or lycopene (four desat-
University of Minnesota urations) from which different acyclic and cyclic
Saint Paul, Minnesota 55108 carotenoids are then synthesized [6] (Figure 1; see Table
1 for genes and plasmids used in this study). In previous
work, we extended this central desaturation pathway
by evolving a six-step phytoene desaturase (CrtI14) ca-Summary
pable of synthesizing the fully conjugated 3,4,3,4-tetra-
dehydrolycopene in E. coli [7]. Lycopene cyclase (CrtY)Previously, we utilized in vitro evolution to alter the
catalyzes the introduction of -rings into either end ofcatalytic functions of several carotenoid enzymes and
lycopene to synthesize ,-carotene, which is then fur-produce the novel carotenoids tetradehydrolycopene
ther modified (Figure 1) [6]. We previously modified CrtYand torulene in Escherichia coli. Here we report on
by directed evolution to generate CrtY2, a variant thatthe successful extension of these pathways and the
cyclizes didehydrolycopene, the precursor of tetradehy-C30 carotenoid diaponeurosporene pathway with ad-
drolycopene, to produce the red carotenoid torulene [7].ditional carotenoid genes. Extension of the known
Starting from C15 farnesyl diphosphate (FDP) insteadacyclic C30 pathway with C40 carotenoid enzymes—
of C20 GGDP as in C40 carotenoid biosynthesis, diversespheroidene monooxygenase and lycopene cyclase—
acyclic C30 diapocarotenoids are synthesized by severalyielded new oxygenated acylic products and the
nonphototrophic bacteria such as Staphylococcus,unnatural cyclic C30 diapotorulene, respectively. Ex-
Streptococcus, and Methylobacterium species [8]. Onlytension of acyclic C40 pathways with spheroidene
the genes encoding dehydrosqualene synthase (crtM)monooxygenase generated novel oxygenated carot-
and dehydrosqualene desaturase (crtN) from Staphylo-enoids including the violet phillipsiaxanthin. Extension
coccus aureus have been cloned and functionally ex-of the torulene biosynthetic pathway with carotene
hydroxylase, desaturase, glucosylase, and ketolase pressed in E. coli, resulting in the production of the
yielded new torulene derivatives. These results dem- yellow 4,4-diaponeurosporene via diapophytoene and
onstrate the utility of extending an in vitro evolved diapo--carotene [9] (Figure 1).
central metabolic pathway with catalytically promis- A number of genes encoding the enzymes for central
cuous downstream enzymes in order to generate carotenoid biosynthetic routes have been cloned, and
structurally novel compounds. genes from different species have been shown to func-
tion cooperatively when combined [10]. Enzymes cata-
lyzing the synthesis and desaturation of acyclic C30 andIntroduction
C40 carotenoid backbones and initial cyclization reac-
tions of C40 carotenoids appear well conserved in carot-To explore the potential of in vitro evolution and meta-
enoid-producing organisms. Less is known, however,bolic engineering strategies to produce novel com-
about the enzymes responsible for the additional struc-pounds in a microbial host, we chose carotenoids as a
tural modifications that contribute to the tremendousmodel system of biotechnological and medical impor-
diversity of natural carotenoids [2]. However, a numbertance [1]. Carotenoids constitute a structurally diverse
of these modifying enzymes have been identified andclass of natural pigments, which are produced as food
colorants, feed supplements and, more recently, as nu- characterized from microbial sources including the
traceuticals and for cosmetic and pharmaceutical pur- monooxygenase from Rhodobacter capsulatus (CrtA)
poses. Although microorganisms and plants synthesize [11]; -carotene ketolase from Synechocystis sp. (CrtO)
more than 600 different carotenoids [2], only a handful [12]; -carotene desaturase from Streptomyces griseus,
can be produced in useful quantities [3]. The discovery Brevibacterioum linens, and Mycobacterium aurum
that carotenoids exhibit significant anticarcinogenic ac- (CrtU) [13–15]; and -carotene hydroxylase (CrtZ) and
tivities and play an important role in the prevention of zeaxanthin glycosylase (CrtX) from Erwinia herbicola [16].
chronic diseases [4, 5] has triggered an increased inter- We sought to probe the catalytic promiscuity of these
est in the synthesis of new carotenoid structures and carotenoid-modifying enzymes toward new carotenoid
the economic production of compounds in engineered substrates synthesized by in vitro evolved biosynthetic
cells. routes. Here we report on the successful extension of
The first committed step in C40 carotenoid biosynthe- the in vitro evolved torulene and tetradehydrolycopene
sis is the extension of the general isoprenoid pathway pathways as well as the wild-type lycopene, -carotene,
by the enzymes geranyl geranyl disphosphate (GGDP) and diaponeurosporene (a C30 carotenoid) pathways
with carotenoid-modifying genes to produce structurally
novel carotenoids in E. coli (Figure 1).*Correspondence: schmi232@tc.umn.edu
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Figure 1. Carotenoids Produced in Recombinant E. coli
Biosynthetic routes to different acyclic and cyclic C40 and C30 carotenoids in engineered E. coli (A) and total carotenoid extracts of E. coli
transformants carrying different recombinant carotenoid pathways (B). Red arrows indicate branching of the central desaturation pathways
to the routes for the biosynthesis of novel carotenoid structures (red). The designation in brackets next to a final product of a carotenoid
route indicates the position in the micro plate array of the corresponding extract from E. coli cells expressing the genes of this pathway. For
enzyme names and functions, see Table 1.
Results and Discussion mass spectrometry showed that, in our system, CrtN
efficiently introduced four double bonds into dehydros-
qualene to predominantly (90%) synthesize the fully con-Coexpression of Dehydrosqualene Synthase CrtM
and Desaturase CrtN Produces the Fully jugated 4,4-diapolycopene in recombinant E. coli (Fig-
ure 2A). This is in contrast to earlier reports where CrtNConjugated C30 Carotenoid Diapolycopene
To extend the isoprenoid pathway in E. coli for synthesis was shown to catalyze efficiently the three-step desatu-
ration of dehydrosqualene leading to the formation ofof C30 carotenoids, two expression cassettes comprising
a constitutive lac-promoter upstream of either crtM or 4,4-diaponeurosporene in recombinant E. coli [9]. How-
ever, shortly before submission of this manuscript, Ar-crtN were assembled to yield pAC-crtM-crtN. E. coli
cells transformed with pAC-crtM-crtN developed a deep nold and coworkers reported the accumulation of 30%
diapolycopene in recombinant E. coli cells constructedyellow-orange color, suggesting the production of dia-
pocarotenoids. Analysis of the cell extracts by HPLC- for directed evolution studies aimed at evolving CrtM
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Table 1. Genes and Plasmids Used in This Study
Accession Number
(A) Gene Enzyme Typical Reaction Catalyzed or Reference
crtM Dehydrosqualene synthase Head-to-head condensation of 2 FDP X73889
crtN Diapophytoene synthase Introduction of 3 desaturations in dehydrosqualene X73889
crtE GGDP synthase Head-to-head condensation of IDP FDP D90087
crtB Phytoene synthase Head-to-head condensation of 2 GGDP D90087
crtI Phytoene desaturase Introduction of 4 desaturations in phytoene D90087
crtI14 In vitro evolved phytoene desaturase Introduction of 6 desaturations in phytoene [7]
crtY Lycopene cyclase Cyclization of -end groups in lycopene to form -rings D90087
crtY2 In vitro evolved lycopene cyclase Cyclization of -end group in didehydrolycopene to form [7]
-ring
crtA Spheroidene monooxygenase Oxygenation at C2 of spheroidene or hydroxysphroidene Z11165
crtO -carotene oxygenase Oxygenation at C4, C4 of -carotene D64004
crtU -carotene desaturase Desaturation/methyltransfer of -rings in -carotene AF139916
crtZ -carotene hydroxylase Hydroxylation of C3, C3 of -carotene D90087
crtX Zeaxanthin glucosylase Glycosylation of C3, C3 of zeaxanthin D90087
(B) Plasmid Properties Reference
pUCmod Constitutive expression vector modified from pUC19, Ap [7]
pACmod Cloning vector modified from pACYC184, Cm [7]
pUC-crtM pUCmod constitutively expressing crtM This study
pUC-crtN pUCmod constitutively expressing crtN This study
pUC-crtY pUCmod constitutively expressing crtY [7]
pUC-crtY2 pUCmod constitutively expressing crtY2 [7]
pUC-crtA pUCmod constitutively expressing crtA This study
pUC-crtO pUCmod constitutively expressing crtO This study
pUC-crtU pUCmod constitutively expressing crtU This study
pUC-crtZ pUCmod constitutively expressing crtZ This study
pUC-crtX pUCmod constitutively expressing crtX This study
pAC-crtM-crtN pACmod constitutively expressing crtM and crtN to This study
produce diaponeurosporene
pAC-crtE-crtB-crtI pACmod constitutively expressing crtE, crtB, and crtI to [7]
produce lycopene
pAC-crtE-crtB-crtI14 pACmod constitutively expressing crtE, crtB, and mutant [7]
crtI14 to produce tetradehydrolycopene
pAC-crtE-crtB-crtI14-crtY pACmod constitutively expressing crtE, crtB, mutant This study
crtI14, and crtY to produce -carotene
pAC-crtE-crtB-crtI14-crtY2 pACmod constitutively expressing crtE, crtB, mutant This study
crtI14, and mutant crtY2 to produce torulene
pAC-crtE-crtB-crtI14-crtY-crtZ pACmod constitutively expressing crtE, crtB, mutant This study
crtI14, crtY, and crtZ to produce zeaxanthin
pAC-crtE-crtB-crtI14-crtY2-crtZ pACmod constitutively expressing crtE, crtB, mutant This study
crtI14, mutant crtY2, and crtZ to produce
monohydroxytorulene
for function in a C40 pathway [17]. Unexpectedly, we may be different and thus increasing its reactivity with
reactive oxygen species like peroxyl-radicals [23].observed that E. coli cells harboring pAC-crtN-crtM also
accumulated significant amounts of polar carotenoids.
Molecular masses and absorption spectra showed them Lycopene Cyclase CrtY Cyclizes the C30
Carotenoid Diaponeuro-sporeneto be various diapolycopene and diaponeurosporene
derivatives carrying methoxy- and/or hydroxy-func- Cyclization of C30 diapocarotenoids, which is a common
modification of C40 carotenoids, is so far unknown. Be-tional groups at one or both of their ends (data not
shown). Acyclic end groups of bacterial C30 diapocaro- cause lycopene cyclase CrtY acts on -end groups [24],
which are the same in acyclic C40 carotenoids (e.g., lyco-tenoids are frequently oxidized to hydroxy, aldehyde, or
carboxy groups, which can be further acylated and/or pene) and C30 carotenoids (e.g., diaponeurosporene or
diapo--carotene), we reasoned that expression of crtYglucosylated [18, 19]. Raisig et al. recently also reported
formation of modified diapocarotenoids in recombinant on pUC-crtY together with the genes for diapolycopene
biosynthesis on pAC-crtM-crtN would produce novelE. coli [20]. Apparently, the diapocarotenoid end groups
are prone to oxidation by free peroxyl-radicals (espe- unnatural cyclic diapocarotenoids in E. coli. Indeed, a
novel cyclic carotenoid along with diaponeurosporenecially hydroperoxyl radicals) formed in lipid membranes
during oxygen stress [21–23]. The observed methoxy was detected in cell extracts of such cotransformed
recombinant E. coli cells (Figure 2B). Absorption andgroups may have formed from hydroperoxyl groups in
the presence of methanol present during isolation and mass spectrum confirmed it to be diapotorulene, the
cyclic derivative of diaponeurosporene. Other possibleanalysis [22]. We never observed significant modifica-
tion of C40 carotenoids, suggesting that the orientation monocyclic and dicyclic diapocarotenoids derived from
diapo--carotene were not detected. As farnesyl diphos-of the C30 carotenoids in the lipid membrane of E. coli
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Figure 2. Analysis of E. coli Cells Producing
C30 Carotenoids
HPLC analysis of carotenoid extracts of E.
coli transformants expressing C30 caroteno-
genic enzymes (CrtM and CrtN) on pAC-crtM-
crtN (A) together with lycopene cyclase pUC-
crtY (B) or spheroidene monooxygenase
pUC-crtA (C). The following diapocaroten-
oids were identified: peak 1, diaponeurospor-
ene (max: 415, 438, 467; M at m/e  402.2);
peak 2, diapolycopene (max: 443, 468, 503;
M at m/e  400.1); peak 3, diapotorulene
(max: 425, 449; M at m/e  402.1); peak 4,
diaponeurosporene-derivative (max: 399, 422,
449; M at m/e 536.3). Double or triple peaks
represent different geometrical isomers. In-
sets: recorded absorption spectra for individ-
ual peaks.
phate (FDP) is the precursor of the C30 biosynthetic path- as the terminal reaction of a sequence involving first
way, the native E. coli FDP synthase (IspA) was overex- hydroxylation at C1,C1 (CrtC) of neurosporene or lyco-
pressed in order to increase the precursor pool and alter pene, followed by desaturation at C3,C4 (C3,C4) (CrtD)
production levels. Expression of the resulting construct and methoxylation at C1,C1 (CrtF) [11, 25]. While CrtC
(pAC-crtM-crtN-ispA) in E. coli increased the diapotoru- and CrtD from Rhodobacter have recently been used to
lene to diaponeurosporene ratio 3- to 5-fold (data not produce different hydroxylated lycopene and didehy-
shown). drolycopene derivatives in E. coli [26], neither the enzy-
matic properties nor the substrate specificity of CrtA
has yet been investigated.Spheroidene Monooxygenase CrtA Oxygenizes
To produce acyclic C30 xanthophylls in engineered E.Acyclic Intermediates of the Diapophytoene
coli cells, we extended the diapolycopene pathway in(C30) Desaturation Pathway
E. coli pAC-crtM-crtN with crtA on pUC-crtA. The co-Although many bacteria produce a large number of dif-
transformed cells appeared more yellow than E. coliferent acyclic xanthophylls (oxygenated carotenoids),
pAC-crtM-crtN. HPLC analysis of the cell extractonly four genes encoding a hydratase (crtC), desaturase
showed three new very polar peaks (Figure 2C). The(crtD), methyl transferase (crtF), and a monooxygenase
absorption maxima and spectral fine structure of the(crtA) have been cloned from Rhodobacter strains [11].
major carotenoid corresponds to an acyclic carotenoidTo obtain acyclic carotenoids with expanded chromo-
without conjugated carbonyl functions and with eightphores, we chose CrtA as a possible enzyme for the
conjugated double bonds as opposed to the nine conju-introduction of keto groups into diapolycopene. In pur-
gated double bonds in diaponeurosporene (Figure 1).ple bacteria under aerobic conditions, CrtA catalyzes
the asymmetrical introduction of one keto group at C2 The two minor peaks showed spectral properties similar
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to diapo--carotene and diapophytoene (data not
shown). Further structural analysis of the yellow carot-
enoid by HPLC-mass spectrometry showed an unex-
pected molecular mass of m/z 536.3 along with the
prominent [M-18] (loss of a hydroxy group) and
[M-58], [M-87] ions (loss of an end group adjacent
to a keto group), indicating a putative C35 backbone
structure rather than C30. Further fragmentation of the
parent ion by MS/MS analysis gave additional unique
[M-18-16] (loss of oxygen from carbonyl group) and
[M-18-28] ions (loss of carbonyl group). Although these
fragmentation patterns are consistent with expected
CrtA end group monooxygenase activity, the high overall
mass suggests a nonspecific activity or unknown biocat-
alytic function of CrtA. More detailed structural analysis
of this compound is currently underway.
Spheroidene Monooxygenase CrtA Oxygenizes
Acyclic Intermediates of the Phytoene (C40)
Desaturation Pathway
In order to generate new, acyclic, purple C40 xantho-
phylls in E. coli from the wild-type lycopene and in vitro
evolved tetradehydrolycopene biosynthetic pathways,
we applied CrtA to introduce keto groups and thus ex-
tend the chromophore of these products.
When lycopene- or tetradehydrolycopene-accumulat-
ing E. coli cells harboring pAC-crtE-crtB-crtI (orange-
red cells) or pAC-crtE-crtB-crtI14 (pink cells) [7] were
cotransformed with pUC-crtA, the cell color changed
Figure 3. Analysis of E. coli Cells Producing Acyclic Oxygenatedto yellow and deep red, respectively (see colored cell
C40 Carotenoidsextracts in Figure 1). All carotenoid extracts were sepa-
HPLC and HP-TLC analysis of carotenoid extracts of E. coli pAC-crtE-rated by high-performance thin layer chromatography
crtB-crtI (A) and E. coli pAC-crtE-crtB-crtI14 (B) both coexpressing(HP-TLC) and high-pressure liquid chromatography
spheroidene monooxygenase (pUC-crtA). The following carotenoids(HPLC) (Figure 3), and structural identification was
were identified: peak 1, -carotene (max: 377, 400, 424; M at m/e achieved by considering their polarity, absorption prop- 540.4); peak 2, neurosporene (max: 419, 442, 470; M at m/e 538.4);
erties, and mass fragmentation patterns (compared to peak 3, lycopene (max: 449, 475, 507; M at m/e  536.4); peak 4,
fragmentation patterns of known carotenoid end groups -carotene-2-one (max: 377, 400, 424; M at m/e  556.4); peak 5,
neurosporene-2-one (max: 419, 442, 470; M at m/e  554.4); peak[27–29]). Extension of the lycopene pathway by coex-
6, lycopene-2-one (max: 449, 475, 507; M at m/e  552.4); peakpression of pUC-crtA with pAC-crtE-crtB-crtI in E. coli
7, phillipsiaxanthin (max: 516, 524; M at m/e  596.3). Double orresulted in the synthesis of three novel acyclic xantho-
triple peaks represent different geometrical isomers. Insets: re-
phylls: -carotene-2-one (7,8,7,8-tetrahydro-1,2-dihy- corded absorption spectra for individual peaks and HP-TLC separa-
dro-,-caroten-2-one), neurosporene-2-one (7,8-dihy- tions.
dro-1,2-dihydro-,-caroten-2-one), and lycopene-2-one
(1,2-dihydro-,-caroten-2-one) (Figure 3A). Unexpect-
Our results show that coexpression of CrtA with acy-edly, the yellow carotenoids -carotene and neurospor-
clic C40 carotenoid pathways can introduce a keto groupene, undetectable intermediates in lycopene producing
at the C(2,2) position of unnatural substrates that doE. coli pAC-crtE-crtB-crtI [7], also accumulated, indicat-
not exhibit a C(3,4) double bond as was previouslying that CrtA uncouples the desaturation sequence cata-
thought to be necessary [6]. In addition, the completelyzed by CrtI. In addition, several minor more polar com-
conversion of tetradehydrolycopene to phillipsiaxanthinpound peaks were observed after HPLC separation.
observed (Figure 3B) suggests it is a favorable substrateThese compounds showed absorption characteristics
for CrtA activity when compared to the incomplete con-of lycopene and neurosporene but with masses corre-
version of lycopene to lycopene-2-one in the presencesponding to the respective diketo- and dihydroxy-diketo-
of CrtA.derivatives (data not shown). A deep purple dihydroxy-
diketo-derivative of tetradehydrolycopene identified as
-Carotene Oxygenase CrtO Introduces Ketophillipsiaxanthin (chemical synthesis and mass frag-
Groups in Torulene and ,-Carotenementation described in [27]) and lycopene constitute
Consequently, the next step was to probe the catalyticthe major carotenoids synthesized by E. coli pAC-crtE-
promiscuity of different cloned ,-carotene-modifyingcrtB-crtI14 coexpressing pUC-crtA. Phillipsiaxanthin is
enzymes toward torulene for the production of novelthe first reported deep purple carotenoid produced in
cyclic carotenoids. To extend the evolved torulene and,recombinant cells. Lycopene-2-one was accumulated
as a control, the wild-type ,-carotene pathway, withas a minor product along with other polar xanthophylls
that could not be identified unequivocally (Figure 3B). different carotenoid genes in E. coli, we cloned lycopene
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Figure 4. Analysis of Carotenoids Produced by Carotene Oxygenase and Desaturase
HPLC analysis of carotenoid extracts of E. coli transformants expressing: (A) pAC-crtE-crtB-crtI14-crtY (,-carotene pathway); (B) pAC-
crtE-crtB-crtI14-crtY2 (evolved torulene pathway); (C) pAC-crtE-crtB-crtI14-crtY; and (D) pAC-crtE-crtB-crtI14-crtY2, extended with carotene
oxygenase CrtO on pUC-crtO; and (E) pAC-crtE-crtB-crtI14-crtY and (F) pAC-crtE-crtB-crtI14-crtY2, extended with carotene desaturase CrtU
on pUC-crtU. The following carotenoids were identified: peak 1, ,-carotene (max: 425, 451, 478; M at m/e  536.4); peak 2, torulene (max:
454, 481, 514; M at m/e  534.4); peak 3, lycopene (max: 449, 475, 507; M at m/e  536.4); peak 4, echinenone (max: 457; M at m/e 
550.4); peak 5, canthaxanthin (max: 463; M at m/e 564.4); peak 6, Ketotorulene (max: 454, 481, 514; M at m/e 548.3); peak 7, isoreniaratene
(max: 425, 451, 478; M at m/e  528.3); peak 8, didehydro-,φ-carotene (max: 454, 481, 514; M at m/e  530.2). Double or triple peaks
represent different geometrical isomers. Insets: recorded absorption spectra for individual peaks.
cyclase crtY or evolved cyclase crtY2 into pAC-crtE- one or both rings of ,-carotene is catalyzed by
-carotene oxygenases or ketolases. Most -carotenecrtB-crtI14 to yield pAC-crtE-crtB-crtI14-crtY and pAC-
crtE-crtB-crtI14-crtY2. E. coli cells harboring pAC-crtE- oxygenases show homology to fatty acid desaturases
and introduce keto groups at both -rings to synthesizecrtB-crtI14-crtY developed a bright orange color due to
the synthesis of ,-carotene, while E. coli cells trans- canthaxanthin, the precursor of the biotechnologically
important carotenoid astaxanthin [30, 31] (Figure 1).formed with pAC-crtE-crtB-crtI14-crtY2 turned bright
red due to the production of torulene and lycopene (Fig- However, -carotene oxygenase CrtO from Synecho-
cystis sp. is unique as it shows high homology to phy-ures 4A and 4B).
The introduction of keto groups at position C4(4) of toene dehydrogenases and has been reported to intro-
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Figure 5. Analysis of Hydroxylated and Glucosylated Carotenoids Produced by Engineered E. coli Cells
HPLC analysis of carotenoid extracts of E. coli cells carrying: (A) pAC-crtE-crtB-crtI14-crtY (,-carotene pathway) and (B) pAC-crtE-crtB-
crtI14-crtY2 (evolved torulene pathway), together with -carotene hydroxylase (crtZ); and (C) pAC-crtE-crtB-crtI14-crtY-crtZ and (D) pAC-
crtE-crtB-crtI14-crtY2-crtZ, together with zeaxanthin glucosylase (crtX). The following carotenoids were identified: peak 1, zeaxanthin (max:
425, 451, 478; M at m/e  568.3); peak 2, hydroxy-torulene (max: 454, 481, 514; M at m/e  550.3); peak 3, -cryptoxanthin-monoglucoside
(max: 425, 451, 478; M at m/e  714.5); peak 4, zeaxanthin-monoglucoside (max: 425, 451, 478; M at m/e  730.5); peak 5, zeaxanthin-
diglucoside (max: 425, 451, 478; M at m/e  892.5); peak 6, torulene-monoglucoside (max: 454, 481, 514; M at m/e  712.4).
duce only one keto group at C4 of one -ring, as present (CrtU) have recently been cloned and characterized in
their homologous hosts [13–15]. The symmetrical aro-in torulene, to synthesize echinenone [12]. We therefore
matization of ,-carotene to isoreneriatene (φ,φ-caro-cotransformed E. coli pAC-crtE-crtB-crtI14-crtY or pAC-
tene) by CrtU involves the introduction of two doublecrtE-crtB-crtI14-crtY2 expressing the ,-carotene or
bonds and a concurrent methyl group shift for eachtorulene pathways, respectively, with pUC-crtO. Sur-
-ring (Figure 1). Because, to our knowledge, successfulprisingly, in our system where each carotenoid enzyme
expression of CrtU in engineered E. coli cells for theis individually expressed under the control of a constitu-
production of aromatic carotenoids such as isorenaria-tive lac-promoter, CrtO introduced keto groups effi-
tene has not yet been reported, we first examinedciently at both rings of ,-carotene to yield canthaxan-
whether CrtU can function cooperatively with other het-thin in a similar ratio to the mono-keto product
erologous carotenoid enzymes in engineered E. coli.echinenone (Figure 4C). The symmetrical activity of CrtO
The exclusive formation of isorenariatene by E. colion ,-carotene was not related to the gene copy num-
pAC-crtE-crtB-crtI14-crtY coexpressed with pUC-crtUber of crtO on pUC-crtO as similar ratios of canthaxan-
proved, therefore, that CrtU functions cooperatively withthin and echinenone were produced by E. coli with the
other carotenoid enzymes assembled from different or-single plasmid system pAC-crtE-crtB-crtI14-crtY-crtO
ganisms (Figure 4E). When E. coli cells harboring pAC-(data not shown). Analysis of extracts from cells ex-
crtE-crtB-crtI14-crtY2 were cotransformed with pUC-pressing the CrtO extended torulene pathway, however,
crtU, a new, more polar major carotenoid accumulatedrevealed synthesis of a new, major carotenoid in addi-
along with isoreniaratene, lycopene, and torulene (Fig-tion to smaller amounts of echinenone, canthaxanthin,
ure 4F) and was identified by adsorption maxima, polar-torulene, and lycopene (Figure 4D). Absorption maxima,
ity, and mass fragmentation spectrum as aromatic toru-
polarity, and mass fragmentation spectrum of this new
lene (didehydro-,φ-carotene).
carotenoid identified it as 4-keto-torulene (Figure 1).
-Carotene Hydroxylase CrtZ and Zeaxanthin
Aromatic Carotenoids Are Produced from Glucosylase CrtX Produce Novel
,-Carotene and Torulene by CrtU Torulene Derivatives
Aromatic carotenoids have been isolated from several The catalytic promiscuity observed for CrtO and CrtU
with torulene suggested that -carotene hydroxylasebacteria, and three bacterial -carotene desaturases
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CrtZ and zeaxanthin glucosylase CrtX, which converts of these pathways with additional genes is a powerful
approach to discover novel natural and unnatural,-carotene to the highly polar zeaxanthin-diglucoside
in, e.g., Erwinia strains [16] (Figure 1), may exhibit similar compounds and produce these compounds in micro-
bial hosts.broad substrate specificities and therefore enable syn-
thesis of a novel polar torulene-glucoside in E. coli. To
extend the torulene and, as a control, the ,-carotene Experimental Procedures
biosynthesis pathway in E. coli with the two enzymes
Cloning and Culture Growth(CrtZ and CrtX) necessary for -ring glucosylation, we
Genes encoding dehydrosqualene synthase (crtM), diapophytoenefirst cloned crtZ into pAC-crtE-crtB-crtI14-crtY (,-car-
synthase (crtN) from Staphylococcus aureus (ATCC 35556D), spher-
otene) and pAC-crtE-crtB-crtI14-crtY2 (torulene) to cre- oidene monooxygenase (crtA) from Rhodobacter capsulatus (DSMZ
ate pAC-crtE-crtB-crtI14-crtY-crtZ and pAC-crtE-crtB- 1710), -carotene oxygenase (crtO) from Synechocystis sp. (ATCC
27184), -carotene desaturase (crtU) from Brevibacterium linenscrtI14-crtY2-crtZ. Pathway extension with CrtZ resulted
(DSMZ 20426), and -carotene hydroxylase (crtZ) and zeaxanthinin the symmetrical hydroxylation of ,-carotene to
glucosylase (crtX) from Erwinia uredovora (Pantoea ananatis DSMZzeaxanthin, which was formed as the only product in E.
30080) were amplified from genomic DNA using a 5 primer con-coli pAC-crtE-crtB-crtI14-crtY-crtZ (Figure 5A). How-
taining at its 5 end a XbaI or EcoRI site followed by an optimized
ever, a new polar carotenoid, with an absorption spec- Shine-Dalgarno sequence (underlined) and a start codon (bold) (5-
trum similar to torulene but with a mass spectrum ex- AGGAGGATTACAAAATG-3) and a 3 primer containing at its 5 end
a EcoRI or NcoI site (Table 1A). PCR products were then digestedpected for hydroxytorulene, accumulated as the main
with restriction enzymes and cloned into the corresponding sitesproduct in E. coli pAC-crtE-crtB-crtI14-crtY2-crtZ (Fig-
of plasmid pUCmod [7] to facilitate constitutive expression from aure 5B), suggesting that torulene and ,-carotene are
modified lac-promoter.equally good substrates for CrtZ. Subsequent combina-
For C30 carotenoid pathway assembly, crtM and crtN were sub-tion in E. coli of pAC-crtE-crtB-crtI14-crtY2/crtY-crtZ, cloned from pUCmod into the SalI (crtM) or a BamHI (crtN) site of
together with the terminal enzyme CrtX of the glucosyla- pACmod [7] by amplification of the genes together with the modified
constitutive lac-promoter, using primers that introduce the corre-tion pathway expressed on pUC-crtX, gave rise to a
sponding restriction enzyme sites at both ends, to give pAC-crtM-number of very polar carotenoid structures in E. coli.
crtN where crtM and crtN have the same orientation as the disruptedThe assembled ,-carotene glucosylation pathway in
tetracycline resistance gene. Likewise, for assembly of theE. coli harboring pAC-crtE-crtB-crtI14-crtY-crtZ and
-carotene and torulene pathways, genes encoding wild-type (crtY)
pUC-crtX produced zeaxanthin-diglucoside as a major or mutant lycopene cyclase (crtY2) were subcloned from pUCmod
product. Other biosynthesis intermediates such as zeax- into the SalI site of pAC-crtE-crtB-crtI14 [7] to give pAC-crtE-crtB-
crtI14-crtY and pAC-crtE-crtB-crtI14-crtY2, respectively (crtY/Y2anthin, zeaxanthin-monoglucoside, and -cryptoxan-
have the same orientation as crtE and crtI14). To assemble thethin-monoglucoside (one -ring of ,-carotene gluco-
glucosylation pathways, crtZ was subcloned similarly into thesylated) were also produced (Figure 5C). Neither
PpmUI site of pAC-crtE-crtB-crtI14-crtY and pAC-crtE-crtB-crtI14-hydroxytorulene nor its precursor torulene accumulated
crtY2 to produce pAC-crtE-crtB-crtI14-crtY-crtZ and pAC-crtE-
in E. coli cells carrying the assembled torulene glycosyl- crtB-crtI14-crtY2-crtZ, respectively (crtZ has the same orientation
ation pathway, but a new carotenoid identified as toru- as crtY/Y2). These plasmids and the carotenoids biosynthetic path-
ways expressed are described in Table 1B.lene glucoside is synthesized in addition to different
For carotenoid production, recombinant E. coli JM109 were culti-hydroxylated and glucosylated ,-carotene derivatives
vated for 48 hr in the dark at 28C in Luria-Bertani (LB) medium (200(Figure 5D). The formation of carotenoids where only
ml medium in a 500 ml flask or 1 l medium in a 3 l flask) supplementedone -ring is hydroxylated or glucosylated indicates that
with the appropriate selective antibiotics chloramphenicol (50
CrtZ and CrtX catalyze -ring modification irrespective 	g/ml) and/or carbenicillin (100 	g/ml).
of the other end structure present in a carotenoid mol-
ecule. Isolation of Carotenoids
Wet cells from a 200 ml (500 mg) or 4 l culture (10 g) were
repeatedly extracted at 4C with a total volume of 30 ml or 400 ml
methanol or acetone until all visible pigments were extracted. AfterSignificance
centrifugation (4C, 6000 rpm), the colored supernatants were
pooled and combined supernatants were centrifuged again, filtratedExtension of an in vitro evolved metabolic pathway
(nylon membrane 0.2	m, Whatman) to remove fine particles, evapo-with a functionally diverse array of modifying enzymes
rated in a vacuum to dryness, and finally resuspended with 30–50
allowed us to engineer pathways for the recombinant ml acetone. The acetone extract was kept at –80C for 1 day to form
production of nine novel carotenoid structures in E. a white precipitate and filtrated with 0.2 	m nylon membrane to
remove the precipitate. The resulting pigment extracts were re-coli. More importantly, several of the novel carotenoids
extracted with an equal volume of ethyl acetate or hexane afterhave never before been isolated in nature (e.g., diapo-
addition of 1/2 volume of saltwater (15% NaCl). The organic phasetorulene) or synthesized in engineered cells (e.g., the
that contained carotenoids was collected and washed with water.first deep purple carotenoid phillipsiaxanthin). These
The collected organic phase was completely evaporated in a vac-
results therefore represent the most extensive exam- uum to dryness at room temperature, resuspended with 0.5–1 ml
ple of combinatorial biosynthesis outside the polyke- hexane, applied to silica gel chromatography (25 
 120 cm), and
eluted stepwise with increasing amount of acetone in hexane (0%tide field. Furthermore, this study shows that modi-
acetone to 30% acetone in hexane basis). The color fractions werefying genes located later in a biosynthetic pathway
then dried under nitrogen gas or in a vacuum and dissolved in 1–2can exhibit a higher catalytic promiscuity than those
ml hexane. A 1–3 	l aliquot of the fractions and the crude extractsearlier in the pathway, allowing them to accept unnatu-
were subjected to high-performance TLC separation for initial analy-
ral substrates. Therefore, we believe that the combina- sis of the crude extract and the color fractions composition on
tion of directed evolution to diverge natural pathways Whatman silica gel 60 A˚ plates (4.5 	m particle size, 200 	m thick-
ness) using the following solvent systems: (1) acetone:hexanetoward new possible metabolic routes and extension
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(40:60) for acyclic C30 and C40 xanthophylls, (2) hexane:chloro- 8. Taylor, R.F. (1984). Bacterial triterpenoids. Microbiol. Rev. 48,
181–189.form:acetone (85:15:20) for diapocarotenoids and cyclic xantho-
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same conditions as the above and carotenoids were eluted with neering towards biotechnological production of carotenoids in
microorganisms. Appl. Microbiol. Biotechnol. 60, 1–11.acetone or methanol. The preparative HPLC, if needed, was carried
out with a semipreparative Zorbax SB-C18 column (9.6 
 250 mm, 11. Armstrong, G., Alberti, M., Leach, F., and Hearst, J. (1989). Nu-
cleotide sequence, organization, and nature of the protein prod-5 	m; Agilent Technologies, Palo Alto, CA), and eluted under iso-
cratic conditions with two solvent systems (A, 90% acetonitrile and ucts of the carotenoid biosynthesis gene-cluster of Rhodo-
bacter capsulatus. Mol. Gen. Genet. 216, 254–268.10% methanol, and B, 90% [acetonitrile:water, 100:15] and 10%
methanol) at a flow rate of 1.5 ml min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